Pharmacokinetics and Pharmacodynamics of a Human Monoclonal Anti-Fgf23 Antibody (KRN23) in the First Multiple Ascending-Dose Trial Treating Adults With X-Linked Hypophosphatemia
Journal of Clinical Pharmacology - United States
doi 10.1002/jcph.570
Full Text
Open PDFAbstract
Available in full text
Categories
Date
August 11, 2015
Authors
Publisher
Wiley